Michael A. Pisetsky, SVP, Ops & Adm/Chief Legal Officer of SI-BONE, Inc., filed a Form 4 on November 6, 2026, disclosing a sale of 36,241 shares of common stock on November 4, 2026, pursuant to a Rule 10b5-1 trading plan.
SI-BONE, Inc. Chief Executive Officer Laura Francis filed a Form 4 on November 6, 2026, disclosing the sale of 75,000 shares of common stock on November 4, 2026, pursuant to a Rule 10b5-1 trading plan.
Walter V. Klemp, CEO, President, and Director of Moleculin Biotech, Inc. (NASDAQ:MBRX), filed a Form 4 on November 6, 2026, disclosing transactions dated November 4, 2026, related to the vesting of restricted stock units.
Moleculin Biotech, Inc. Chief Science Officer Donald H. Picker filed a Form 4 on November 6, 2026, reporting transactions in common stock and restricted stock units dated November 4, 2026, on NASDAQ:MBRX.
Jonathan P. Foster, Chief Financial Officer of Moleculin Biotech, Inc. (NASDAQ:MBRX), filed a Form 4 on November 6, 2026, reporting transactions dated November 4, 2026, related to the vesting of restricted stock units.
Director Ingrid Burton of Extreme Networks Inc filed a Form 4 with the SEC on November 6, 2026, reporting both the vesting of existing restricted stock units and the grant of new restricted stock units on November 4, 2026.
Ryan A. King, Co-Founder, Director, and Officer of Chime Financial, Inc. (NASDAQ:CHYM), filed a Form 4 on November 6, 2026, disclosing transactions in Class A Common Stock and Class B Common Stock dated November 5, 2026.
Jon M. Foster, Executive Vice President and Chief Operating Officer of HCA Healthcare, Inc. (NYSE:HCA), filed a Form 4 on November 6, 2026, disclosing a series of common stock transactions dated November 4 and November 6, 2026.
Mary K. Moreland, Executive Vice President of Abbott Laboratories, filed a Form 4 on November 6, 2026, disclosing a sale of common shares on November 5, 2026.
Saba Capital Management, L.P. filed a Form 4 on November 6, 2026, disclosing a purchase of common stock in Japan Smaller Capitalization Fund Inc (NYSE:JOF) on November 5, 2026.